adalimumab

The drug is used for the treatment of rheumatoid arthritis, various forms of juvenile idiopathic arthritis, axial spondyloarthritis (including ankylosing spondylitis), psoriatic arthritis, psoriasis (in adults and children), hidradenitis suppurativa, Crohn's disease and ulcerative colitis (in adults and children), as well as uveitis (in adults and children).

Form: solution for injection

ATC: L04AB04

Manufacturer: Pfizer Service Company BV (batch release)

The drug is prescribed for the treatment of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and uveitis. It is also used in children for the treatment of juvenile idiopathic arthritis and other specified diseases.

Form: solution for injection

ATC: L04AB04

Manufacturer: Catalent Belgium (manufacturing of sterile liquid dosage forms in single-use prefilled glass syringes of type I with stainless steel needle, needle cap with rigid sheath and rubber seal; quality control at batch release for sterility and endotoxins)

The drug is prescribed for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and uveitis.

Form: solution for injection

ATC: L04AB04

Manufacturer: Novartis Pharmaceutical Manufacturing GmbH (full production cycle; batch control)

The drug is prescribed for the treatment of polyarticular juvenile idiopathic arthritis, enthesitis-associated arthritis, Crohn's disease, plaque psoriasis, and chronic non-infectious anterior uveitis in children.

Form: solution for injection

ATC: L04AB04

Manufacturer: Wetter Pharma-Vertrieb GmbH & Co. KG (manufacturing of medicinal product, primary packaging of bulk pre-filled syringes, testing (sterility and bacterial endotoxins); secondary packaging of bulk pre-filled syringes, testing (sterility and bacterial endotoxins))

The drug is prescribed for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (axial spondyloarthritis), Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is also used in children for juvenile forms of arthritis and other conditions specified in the indications.

Form: solution for injection

ATC: L04AB04

Manufacturer: Wetter Pharma-Vertrieb GmbH & Co. KG (manufacturing of medicinal product, primary packaging of bulk pre-filled syringes, testing (sterility and bacterial endotoxins); secondary packaging of bulk pre-filled syringes, testing (sterility and bacterial endotoxins))

The drug is prescribed for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and uveitis.

Form: solution for injection

ATC: L04AB04

Manufacturer: Novartis Pharma Stein AG (quality control (chemical/physical))

The drug is prescribed for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, pyoderma gangrenosum (hidradenitis suppurativa), Crohn's disease, ulcerative colitis, and uveitis.

Form: solution for injection

ATC: L04AB04

Manufacturer: Novartis Pharmaceutical Manufacturing GmbH (full production cycle; batch control)